Announcements Trials
Browse Landscape

Status

Not yet recruiting 3Unknown 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 61Observational 5

Sponsor

Cancer Type

Other solid neoplasm 2Gynecologic 2Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 1Locally Advanced Rectal Carcinoma 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Advanced Solid Tumor 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × envafolimab × Clear all
NCT07562347 2026-05-01

ENCOMPASS STUD

IR INNOVATE RESEARCH PRIVATE LIMITED

Not yet recruiting
120 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06643208 2025-06-26

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Fujian Provincial Hospital

Recruiting
37 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT06010667 2023-08-24

A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

Hebei Medical University Fourth Hospital

Not yet recruiting
60 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT05879796 2023-05-30

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Peking University Third Hospital

Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05645094 2022-12-13

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Fudan University

Not yet recruiting
38 enrolled
GastrointestinalOther solid neoplasm

Locally Advanced Rectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡